Press Release
Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...
QMENTA, the experts in medical imaging, Announces Appointment of John E. Kelly III, PhD to Board of Advisors
Boston, MA, March 29, 2023— QMENTA, Inc. announced today that John E. Kelly III, PhD has been appointed to the company's Board of Advisors. Dr. Kelly...
Cloud AI Medical Imaging Expert QMENTA, Inc. Announces FDA 510(k) Clearance of Platform at RSNA 2021
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
Countdown to RSNA 2021: Key Announcements from QMENTA, Booth 6633
We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has...
QMENTA Launches AI Imaging Biomarker Analysis Catalog at RSNA 2021
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses
QMENTA CEO Vesna Prchkovska wins Gold Female Entrepreneur of the Year in the 2021 STEVIE AWARDS FOR WOMEN IN BUSINESS
QMENTA CEO Vesna Prchkovska wins Gold Female Entrepreneur of the Year in the 2021 STEVIE AWARDS FOR WOMEN IN BUSINESS
Announcing Leadership Changes at QMENTA
ANNOUNCING LEADERSHIP CHANGES AT QMENTA – NEW CEO APPOINTED AND...